viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 4545
tüüp :
ajaleht
interneti link :
10.1272/jnms.JNMS.2022_89-104
uurimisrühmad :
Tokyo - Nippon Medical School Hospital, Department of Pharmacy
Autor :
Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H.
pealkiri :
Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
publikatsioon :
Journal of Nippon Medical school 2021
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Dexmedetomidine
4 µg/ml
+
Nafamostat
10 mg/mL
+
Fentanyl citrate
50 µg/ml
+
Nafamostat
10 mg/mL
+
Midazolam hydrochloride
5 mg/ml
+
Nafamostat
10 mg/mL
+
Morphine hydrochloride
2 mg/ml
+
Nafamostat
10 mg/mL
+
Nafamostat
10 mg/mL
+
Dexmedetomidine
4 µg/ml
+
10 mg/mL
+
Fentanyl citrate
50 µg/ml
+
10 mg/mL
+
Midazolam hydrochloride
5 mg/ml
+
10 mg/mL
+
Morphine hydrochloride
2 mg/ml
+
10 mg/mL
+
Rocuronium bromide
10 mg/ml
+
Rocuronium bromide
10 mg/ml
+
Nafamostat
10 mg/mL
+
Mentions Légales
